International Cerebral Palsy
Genomics Consortium

About

In March 2017, the International Cerebral Palsy Genomics Consortium (ICPGC) was formed. It is an unincorporated collaboration among entities and individuals pursuing the common mission of accelerating progress in cerebral palsy genomic research. The consortium aims to achieve this goal by advancing a common infrastructure of genomics and clinical data, and harmonising approaches to enable effective and responsible sharing of genomics and health-related data.

Objectives

Our goal is to work as an integrated, collaborative international network of clinicians, researchers, and advocates in order to unlock the molecular basis of cerebral palsy using genomics and related tools, and to facilitate the development of novel therapies to improve the health and quality of life of individuals with cerebral palsy.

CP Governance

The ICPGC Governance Council manages the overall scientific direction of the ICPGC, its business and affairs including, but not limited to: scientific priorities; strategy regarding funding support; review of new consortium membership; interaction with stakeholders including governments, funders, non-profit and non-governmental organizations, advocacy groups, and others; and all other matters identified from time to time as requiring GC review, including matters arising from periodic ICPGC conference meetings.

Governance Chair

Name:  Dr. Michael Kruer, MD

Position: Director, Pediatric Movement Disorders Program, Phoenix Children’s Hospital; Associate Professor, University of Arizona

Affiliations: Barrow Neurological Institute, Phoenix Children’s Hospital; Departments of Child Health, Cellular & Molecular Medicine, Neurology and Genetics, University of Arizona College of Medicine Phoenix, USA

Location: Phoenix, AZ, USA  www.kruerlab.org

Governance Members

Dr. Gareth Baynam, MBBS, FRACP, MACHI, PhD
Head, Western Australian Register of Developmental Anomalies; Director, Undiagnosed Diseases Program WA; and Clinical Geneticist, Genetic Services of Western Australia.

Affiliations: Western Australian Department of Health – Genetic Services of Western Australia; Western Australian Register of Developmental Anomalies; Office of Population Health Genomics, Public and Aboriginal Health Division.

Location: Perth, Australia

Dr. Michael Fahey, MBBS (Hons), PhD, FRACP
Director of Neurogenetics ; Head of Child Neurology

Affiliations: Monash Paediatrics, Monash University; Monash Children’s Hospital

Location: Melbourne, Australia

More info

Dr. Jozef Gecz, PhD, FAA, FAAHMS, FFSc(RCPA)
Chair for the Prevention of Childhood Disability; NH&MRC Senior Principal Research Fellow

Affiliations: The Robinson Research Institute, The University of Adelaide; Adelaide Medical School, The University of Adelaide; and South Australian Health and Medical Sciences Institute

Location: Adelaide, Australia

More info

Dr. Andres Moreno De Luca, MD
Assistant Professor, Autism & Developmental Medicine Institute and Genomics Medicine Institute; and Associate Neuroradiologist, Department of Radiology, Geisinger 

Affiliations: Autism & Developmental Medicine Institute, Geisinger Health System; and Department of Radiology, Geisinger

Location: Lewisburg, PA, USA

More info

Ms. Yana Wilson, MIPH
Research Officer

Affiliations: Cerebral Palsy Alliance Research Institute, University of Sydney; Garvan Institute of Medical Research

Location: Sydney, Australia

More info

Dr. Richard Wintle, PhD
Assistant Director, The Centre for Applied Genomics; Assistant Director, CP-NET Cerebral Palsy Integrated Discovery Network

Affiliations: The Centre for Applied Genomics and Programme in Genetics and Genome Biology, The Hospital for Sick Children; CP-NET Cerebral Palsy Integrated Discovery Network

Location: Toronto, Canada

More info

Dr. Changlian Zhu, MD, PhD
Paediatrician / Associate Professor

Affiliations: University of Gothenburg; Zhengzhou University

Location: Gothenburg, Sweden; Zhengzhou, China

More info

CP Consumer Community Group

Members of this group come from all around the world to assist the governance committee by offering a perspective from people with CP and their families.

ICPGC Members

KML-LogoFullscreen-LogoQR-code-logoGeoJSON-LogoGeoRSS-Logo
ICPGC

loading map - please wait...

Cerebral Palsy Alliance Research Institute, Sydney: -33.888200, 151.177000
Monash University, Melbourne: -37.911600, 145.146000
Royal Children’s Hospital / Murdoch Children’s Research Institute, Melbourne: -37.778466, 144.947197
The Children’s Hospital Westmead, Sydney: -33.801028, 150.991577
University of Adelaide: -35.016500, 138.573000
Women’s and Children’s Hospital (SA), Adelaide: -34.912600, 138.599000
Western Australian Register of Developmental Anomalies, Pert: -31.950400, 115.825000
Holland-Bloorview Research Institute, Toronto: 43.718268, -79.374123
The Centre for Applied Genomics, The Hospital for Sick Children, Toronto: 43.657033, -79.388557
McGill University, Montreal: 45.506167, -73.577641
Children\'s Hospital and Institutes of Biomedical Sciences: 31.169200, 121.389307
Zhengzhou University: 34.811753, 113.540615
Israel: 32.085300, 34.781768
Turkey: 41.009600, 28.965200
Universidad Pablo de Olavide: 37.358170, -5.949880
University of Gothenburg: 57.707200, 11.967000
Geisinger Health System: 40.967740, -76.603476
University of Arizona: 33.480400, -112.017000
Yale University: 41.316324, -72.922343

ICPGC Funding

ICPGC Partners